Vandenberg D&B, short for Data and Bio, was founded to help companies navigate the borders between vaccine / immune technology and data science. We offer strategic advice on data science strategy, from analysis to processes, and translational science. Our customers are vaccine and biotech companies and investors keen on investing in these companies. We bring over a decade of experience with vaccine technologies like adjuvants, adenoviral vectors, and RNA. Moreover, we bring two decades of experience in data science translating biological questions into data science questions. Additionally, we have extensive experience in the practicalities of making data available to the scientists who need them.